National Human Genome Research Institute (NHGRI)
Study Description: The purpose of this study is to 1) describe the clinical phenotypes of the various forms of MMA and cobalamin disorders, explore their associations with selected biochemical, enzymatic and other organ-specific parameters in order to better understand the pathophysiology of these disorders and 2) explore correlations between clinical parameters, enzymatic function and molecular genetics. Objectives: * To characterize the phenotypic spectrum of methylmalonic acidemias, cobalamin metabolism and related disorders * To understand the natural history of multisystem involvement associated with each of the disorders and the associations with molecular, enzymatic, metabolic and other clinical parameters and biomarkers * To correlate genotypes with the phenotypes observed and elucidate the underlying pathophysiology of each disorder * To understand the risk and benefits achieved with current therapeutic measures, such as diet, small molecule treatments and liver and/or kidney transplantation. * To characterize longitudinal changes in clinical outcomes and biomarkers to identify measures that may serve as clinical outcome assessments or biomarkers in future interventional trials Endpoints: * Age at symptom onset, age at diagnosis, clinical symptoms at diagnosis, frequency of clinical manifestations * Change in clinical manifestations over time such as visual acuity, renal function, cognitive function and their correlation with changes in disease biomarkers * Association between genetic variants, the presence or absence of disease symptoms and/or clinical severity * Frequency or severity of disease manifestations with various treatments * Change in clinical outcomes over time, variability in the population, correlation between outcome assessments and disease severity.
Study Description: The purpose of this study is to 1) describe the clinical phenotypes of the various forms of MMA and cobalamin disorders, explore their associations with selected biochemical, enzymatic and other organ-specific parameters in order to better understand the pathophysiology of these disorders and 2) explore correlations between clinical parameters, enzymatic function and molecular genetics. Objectives: * To characterize the phenotypic spectrum of methylmalonic acidemias, cobalamin metabolism and related disorders * To understand the natural history of multisystem involvement…
* INCLUSION CRITERIA Individuals with a biochemical or genetic diagnosis of methylmalonic acidemia or cobalamin disorders of any sex or ethnicity, and over 1 month of age are eligible to enroll in this protocol as well as those with suspected genetic but unknown type of MMA. Family members of affected subjects and healthy volunteers 18+ are also eligible for a subset of procedures. Individuals with methylmalonic acidemia or cobalamin disorders of any age, sex, and ethnicity, undergoing a transplantation surgery at UPMC Children's Hospital of Pittsburgh, are eligible to participate in the tis…